Human genetic studies have demonstrated that triggering receptor expressed in myeloid cells 2 (TREM2) coding variants have a strong association with Alzheimer’s disease (AD) and other neurodegenerative diseases. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.